Merck to stop lung condition drug study early due to strong efficacy data
Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...
Dewpoint Therapeutics Announces DPTX3496 as a Development Candidate for the Treatment of Colorectal, Breast, and Lung Cancers
Dewpoint Therapeutics’ second development candidate, DPTX3496 is an oral, small molecule acting via a novel ...
Boston hospital offers one-visit procedure to treat lung cancer
BOSTON - Patients with lung nodules often have to undergo several procedures including biopsy and multiple surgeries, but a ...
The American Journal of Managed Care2h
5 Potential Therapeutic Targets for Small Cell Lung Cancer
According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...
dermatologyadvisor1h
FDA Alert: Pulmonology Drug Approvals, Recalls, and Device Updates
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
This Arizona company has been an innovator in cancer research, treatment for 4 decades. Here's how
Patients might not know about Roche Tissue Diagnostics, but the Arizona entity has been testing for cancer and helping devise ...
Targeted Oncology2h
Tailoring CDS Tool Improves Biomarker Documentation in Cancer Treatment
Daniel Rubin, PharmD, BCOP, discussed a study showing how a clinical decision support tool can improve the documentation of ...
Lung cancer symptoms: 6 early signs of the disease that can help in early diagnosis
The World Health Organisation (WHO) says that lung cancer is often diagnosed at advanced stages when treatment options are ...
American Cancer Society2h
How Telehealth Visits Can Help Support You During Cancer
A recent study published in JAMA explored whether getting telehealth visits, rather than in-person visits, affects the ...
FierceBiotech2d
Cullinan plans approval application for lung cancer drug this year based on phase 2 win
Cullinan Therapeutics has announced that its lead asset has aced a midstage lung cancer trial—but the biotech is keeping the ...
Science Daily3h
AI boosts efficacy of cancer treatment, but doctors remain key
A new study shows that artificial intelligence (AI) can help doctors make better decisions when treating cancer. However, it also highlights challenges in how doctors and AI work together. The study ...
WVU Cancer Institute offers pioneering lung cancer treatment
The WVU Cancer Institute is the first provider in the state to offer a new and promising treatment for extensive-stage small cell lung cancer. Extensive stage means the cancer has spread within the ...